FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012068175> ?p ?o ?g. }

• W3012068175 abstract "Abstract Background Although current guidelines for AKI suggested against the use of furosemide in AKI management, the effect of furosemide on outcomes in real-world clinical settings remains uncertain. The aim of the present study was to investigate the association between furosemide administration and outcomes in critically ill patients with AKI using real-world data. Methods Critically ill patients with AKI were identified from the Medical Information Mart for Intensive Care (MIMIC)-III database. Propensity score (PS) matched analysis was used to match patients receiving furosemide to those without diuretics treatment. Linear regression, logistic regression model, and Cox proportional hazards model were used to assess the associations between furosemide and length of stay, recovery of renal function, and in-hospital and 90-day mortality, respectively. Results A total of 14,154 AKI patients were included in the data analysis. After PS matching, 4427 pairs of patients were matched between the patients who received furosemide and those without diuretics treatment. Furosemide was associated with reduced in-hospital mortality [hazard ratio (HR) 0.67; 95% CI 0.61–0.74; P < 0.001] and 90-day mortality [HR 0.69; 95% CI 0.64–0.75; P < 0.001], and it was also associated with the recovery of renal function [HR 1.44; 95% CI 1.31–1.57; P < 0.001] in over-all AKI patients. Nevertheless, results illustrated that furosemide was not associated with reduced in-hospital mortality in patients with AKI stage 0–1 defined by UO criteria, AKI stage 2–3 according to SCr criteria, and in those with acute-on-chronic (A-on-C) renal injury. Conclusions Furosemide administration was associated with improved short-term survival and recovery of renal function in critically ill patients with AKI. Furosemide was especially effective in patients with AKI UO stage 2–3 degree. However, it was not effective in those with AKI SCr stage 2–3 and chronic kidney disease. The results need to be verified in randomized controlled trials." @default.
• W3012068175 created "2020-03-23" @default.
• W3012068175 creator A5005392397 @default.
• W3012068175 creator A5008484285 @default.
• W3012068175 creator A5036976022 @default.
• W3012068175 creator A5047441201 @default.
• W3012068175 creator A5061023059 @default.
• W3012068175 creator A5068910005 @default.
• W3012068175 creator A5070248884 @default.
• W3012068175 creator A5072024653 @default.
• W3012068175 creator A5075546782 @default.
• W3012068175 date "2020-03-04" @default.
• W3012068175 modified "2023-10-16" @default.
• W3012068175 title "Association between furosemide administration and outcomes in critically ill patients with acute kidney injury" @default.
• W3012068175 cites W1974181209 @default.
• W3012068175 cites W1980969694 @default.
• W3012068175 cites W1989103581 @default.
• W3012068175 cites W2000262578 @default.
• W3012068175 cites W2007000302 @default.
• W3012068175 cites W2011458442 @default.
• W3012068175 cites W2025128142 @default.
• W3012068175 cites W2028618147 @default.
• W3012068175 cites W2035192046 @default.
• W3012068175 cites W2058528866 @default.
• W3012068175 cites W2080845580 @default.
• W3012068175 cites W2081359434 @default.
• W3012068175 cites W2083548531 @default.
• W3012068175 cites W2105284628 @default.
• W3012068175 cites W2108293285 @default.
• W3012068175 cites W2111704803 @default.
• W3012068175 cites W2119226572 @default.
• W3012068175 cites W2133442735 @default.
• W3012068175 cites W2145711589 @default.
• W3012068175 cites W2167076563 @default.
• W3012068175 cites W2167501720 @default.
• W3012068175 cites W2346781540 @default.
• W3012068175 cites W2396881363 @default.
• W3012068175 cites W2467227824 @default.
• W3012068175 cites W2735071354 @default.
• W3012068175 cites W2799933149 @default.
• W3012068175 cites W2886396074 @default.
• W3012068175 cites W2893893301 @default.
• W3012068175 cites W2963386643 @default.
• W3012068175 doi "https://doi.org/10.1186/s13054-020-2798-6" @default.
• W3012068175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7057586" @default.
• W3012068175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32131879" @default.
• W3012068175 hasPublicationYear "2020" @default.
• W3012068175 type Work @default.
• W3012068175 sameAs 3012068175 @default.
• W3012068175 citedByCount "51" @default.
• W3012068175 countsByYear W30120681752020 @default.
• W3012068175 countsByYear W30120681752021 @default.
• W3012068175 countsByYear W30120681752022 @default.
• W3012068175 countsByYear W30120681752023 @default.
• W3012068175 crossrefType "journal-article" @default.
• W3012068175 hasAuthorship W3012068175A5005392397 @default.
• W3012068175 hasAuthorship W3012068175A5008484285 @default.
• W3012068175 hasAuthorship W3012068175A5036976022 @default.
• W3012068175 hasAuthorship W3012068175A5047441201 @default.
• W3012068175 hasAuthorship W3012068175A5061023059 @default.
• W3012068175 hasAuthorship W3012068175A5068910005 @default.
• W3012068175 hasAuthorship W3012068175A5070248884 @default.
• W3012068175 hasAuthorship W3012068175A5072024653 @default.
• W3012068175 hasAuthorship W3012068175A5075546782 @default.
• W3012068175 hasBestOaLocation W30120681751 @default.
• W3012068175 hasConcept C126322002 @default.
• W3012068175 hasConcept C159641895 @default.
• W3012068175 hasConcept C177713679 @default.
• W3012068175 hasConcept C17923572 @default.
• W3012068175 hasConcept C207103383 @default.
• W3012068175 hasConcept C2777955127 @default.
• W3012068175 hasConcept C2779541074 @default.
• W3012068175 hasConcept C2780472472 @default.
• W3012068175 hasConcept C2991859549 @default.
• W3012068175 hasConcept C44249647 @default.
• W3012068175 hasConcept C50382708 @default.
• W3012068175 hasConcept C71924100 @default.
• W3012068175 hasConceptScore W3012068175C126322002 @default.
• W3012068175 hasConceptScore W3012068175C159641895 @default.
• W3012068175 hasConceptScore W3012068175C177713679 @default.
• W3012068175 hasConceptScore W3012068175C17923572 @default.
• W3012068175 hasConceptScore W3012068175C207103383 @default.
• W3012068175 hasConceptScore W3012068175C2777955127 @default.
• W3012068175 hasConceptScore W3012068175C2779541074 @default.
• W3012068175 hasConceptScore W3012068175C2780472472 @default.
• W3012068175 hasConceptScore W3012068175C2991859549 @default.
• W3012068175 hasConceptScore W3012068175C44249647 @default.
• W3012068175 hasConceptScore W3012068175C50382708 @default.
• W3012068175 hasConceptScore W3012068175C71924100 @default.
• W3012068175 hasFunder F4320321001 @default.
• W3012068175 hasIssue "1" @default.
• W3012068175 hasLocation W30120681751 @default.
• W3012068175 hasLocation W30120681752 @default.
• W3012068175 hasLocation W30120681753 @default.
• W3012068175 hasLocation W30120681754 @default.
• W3012068175 hasOpenAccess W3012068175 @default.
• W3012068175 hasPrimaryLocation W30120681751 @default.
• W3012068175 hasRelatedWork W2001212741 @default.
• W3012068175 hasRelatedWork W2345211651 @default.
• W3012068175 hasRelatedWork W2523868935 @default.

• next